SE321676B - - Google Patents

Info

Publication number
SE321676B
SE321676B SE3179/66A SE317966A SE321676B SE 321676 B SE321676 B SE 321676B SE 3179/66 A SE3179/66 A SE 3179/66A SE 317966 A SE317966 A SE 317966A SE 321676 B SE321676 B SE 321676B
Authority
SE
Sweden
Application number
SE3179/66A
Inventor
C Huebner
Original Assignee
Ciba Geigy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy filed Critical Ciba Geigy
Publication of SE321676B publication Critical patent/SE321676B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SE3179/66A 1962-06-19 1966-03-10 SE321676B (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20343662A 1962-06-19 1962-06-19
US21189462A 1962-07-23 1962-07-23
US267810A US3253037A (en) 1962-06-19 1963-03-25 N-2-alkynyl-amino-benzocylo-alkanes

Publications (1)

Publication Number Publication Date
SE321676B true SE321676B (fr) 1970-03-16

Family

ID=27394548

Family Applications (3)

Application Number Title Priority Date Filing Date
SE6752/63A SE317370B (fr) 1962-06-19 1963-06-18
SE3178/66A SE321926B (fr) 1962-06-19 1966-03-10
SE3179/66A SE321676B (fr) 1962-06-19 1966-03-10

Family Applications Before (2)

Application Number Title Priority Date Filing Date
SE6752/63A SE317370B (fr) 1962-06-19 1963-06-18
SE3178/66A SE321926B (fr) 1962-06-19 1966-03-10

Country Status (10)

Country Link
US (1) US3253037A (fr)
AT (2) AT244331B (fr)
BE (1) BE633762A (fr)
BR (1) BR6349933D0 (fr)
CH (3) CH455752A (fr)
DE (1) DE1443599A1 (fr)
ES (1) ES289141A1 (fr)
FR (1) FR3290M (fr)
GB (1) GB1003686A (fr)
SE (3) SE317370B (fr)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1187017A (en) * 1966-07-16 1970-04-08 Aspro Nicholas Ltd Substituted 1-Amino Indanes and Tetrahydronaphthalens
US3485874A (en) * 1966-05-04 1969-12-23 Chinoin Gyogyszer Es Vegyeszet Ortho and para bromophenyl isopropyl methylamines
US3852339A (en) * 1970-06-15 1974-12-03 Squibb & Sons Inc Aminoalkoxyphenylurea derivatives
FR2319332A1 (fr) * 1975-07-28 1977-02-25 Roussel Uclaf Nouveaux derives de l'aminobenzocycloheptene et leurs sels, procede de preparation et application a titre de medicaments desdits produits
US4320148A (en) * 1980-11-24 1982-03-16 Smithkline Corporation 2-Aminotetralin compounds, pharmaceutical compositions and method of producing central alpha1 agonist activity
US4542153A (en) * 1981-05-06 1985-09-17 The Ohio State University Research Foundation Methods for changing calcium metabolism within the cells of a mammal
US4393226A (en) * 1981-05-06 1983-07-12 The Ohio State University Research Foundation Compounds and methods for changing calcium metabolism within the cells of a mammal
US5214156A (en) * 1988-03-25 1993-05-25 The Upjohn Company Therapeutically useful tetralin derivatives
IL114715A (en) * 1989-02-27 1997-01-10 Lilly Co Eli Intermediate compounds for ring-substituted 2-amino-1, 2, 3, 4-tetrahydronaphthalenes and 3-aminochromanes
US5744500A (en) 1990-01-03 1998-04-28 Teva Pharmaceutical Industries, Ltd. Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof
IL92952A (en) * 1990-01-03 1994-06-24 Teva Pharma R-enantiomers of n-propargyl-1-aminoindan compounds, their preparation and pharmaceutical compositions containing them
US5844003A (en) * 1991-04-04 1998-12-01 Innovations Foundation Use of deprenyl compounds to maintain, prevent loss, or recover nerve cell function
IL99759A (en) * 1991-10-16 1997-06-10 Teva Pharma Mono-fluorinated derivatives of n-propargyl-1-aminoindan, their preparation and pharmaceutical compositions containing them
US5914349A (en) * 1994-01-10 1999-06-22 Teva Pharmaceutical Industries, Ltd. Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives
WO1995018617A1 (fr) * 1994-01-10 1995-07-13 Teva Pharmaceutical Industries Ltd. Derives de 1-amino-indane et leurs compositions
PT966435E (pt) 1996-12-18 2005-06-30 Yissum Res Dev Co Derivados aminoindano
US6737547B1 (en) 1998-12-31 2004-05-18 Teva Pharmaceutical Industries, Ltd. Compositions containing and methods of using N-acyl-1H-aminoindenes
US20040010038A1 (en) * 2002-02-27 2004-01-15 Eran Blaugrund Propargylamino indan derivatives and propargylamino tetralin derivatives as brain-selective MAO inhibitors
CA2588293C (fr) * 2004-11-24 2013-07-02 Teva Pharmaceutical Industries Ltd. Compositions de rasagiline delitantes oralement
CA2620476A1 (fr) * 2005-06-02 2006-12-07 Jenrin Discovery Inhibiteurs de la mao-b utilises pour traiter l'obesite
CN101622225B (zh) * 2005-11-17 2015-04-15 泰华制药工业有限公司 炔丙基氨基茚分离方法
EP1956904B1 (fr) * 2005-12-09 2017-04-12 Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. Ladostigil a faible dose pour le traitement du déficit cognitif léger
TW200744576A (en) * 2006-02-24 2007-12-16 Teva Pharma Propargylated aminoindans, processes for preparation, and uses thereof
EP2053033A1 (fr) 2007-10-26 2009-04-29 Bayer Schering Pharma AG Composants à utiliser dans l'imagerie, le diagnostic et/ou le traitement des maladies du système nerveux central ou des tumeurs
JP5425806B2 (ja) 2007-12-24 2014-02-26 シプラ・リミテッド プロパルギル化アミノインダン誘導体の合成方法
EP2328861A2 (fr) * 2008-07-11 2011-06-08 Synthon BV Polymorphes de chlorhydrate de rasagiline
EP2358658A4 (fr) 2008-11-20 2012-11-14 Reddys Lab Ltd Dr Préparation de rasagiline et de ses sels
CA2767592A1 (fr) * 2009-07-09 2011-01-13 Ratiopharm Gmbh Sels de rasagiline et leurs preparations pharmaceutiques
EP2325159A1 (fr) 2009-11-24 2011-05-25 LEK Pharmaceuticals d.d. Nouveaux sels de rasagiline
EP2610239A1 (fr) 2012-01-02 2013-07-03 Dr. Reddy's Laboratories Ltd. Préparation de rasagiline hémitartrate
WO2017190107A1 (fr) * 2016-04-29 2017-11-02 Board Of Regents, The University Of Texas System Liants de récepteur sigma

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3201470A (en) * 1965-08-17 Chsx c cech

Also Published As

Publication number Publication date
GB1003686A (en) 1965-09-08
CH455752A (de) 1968-05-15
CH466269A (de) 1968-12-15
SE321926B (fr) 1970-03-23
BE633762A (fr) 1963-12-18
AT244331B (de) 1965-12-27
BR6349933D0 (pt) 1973-08-28
FR3290M (fr) 1965-05-03
ES289141A1 (es) 1963-11-16
CH462154A (de) 1968-09-15
SE317370B (fr) 1969-11-17
US3253037A (en) 1966-05-24
AT244951B (de) 1966-02-10
DE1443599A1 (de) 1968-10-24

Similar Documents

Publication Publication Date Title
BE616548R (fr)
BE625846A (fr)
BE616785A (fr)
BE635383A (fr)
BE634920A (fr)
BE632886A (fr)
BE632610A (fr)
BE632501A (fr)
BE632314A (fr)
BE632285A (fr)
BE631375A (fr)
BE630010A (fr)
SE317370B (fr)
BE628345A (fr)
BE628305A (fr)
BE612311A (fr)
BE627278A (fr)
BE626188A (fr)
BE616920A (fr)
BE616490A (fr)
BE616386A (fr)
BE616166A (fr)
BE615962A (fr)
BE615849A (fr)
BE615804A (fr)